Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2000
03/30/2000WO2000017198A1 3-bicycloindole compounds as 5-ht1d ligands
03/30/2000WO2000016777A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
03/30/2000WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/30/2000WO2000016603A2 Bridged heterocyclic derivatives
03/30/2000WO1999062908A3 Cell adhesion-inhibiting antinflammatory compounds
03/30/2000CA2344670A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
03/30/2000CA2344376A1 Bridged heterocyclic derivatives
03/30/2000CA2344251A1 Tetrahydropyridoethers
03/30/2000CA2343391A1 3-bicycloindole compounds as 5-ht1d ligands
03/30/2000CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/29/2000EP0989129A1 Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof
03/29/2000EP0989119A1 Process and intermediates for preparing trovafloxacin acid salts
03/29/2000EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
03/29/2000EP0988302A1 Benzonaphthyridines
03/29/2000EP0988045A1 Peptide nucleic acid monomers and oligomers
03/29/2000EP0988036A1 Use of diketone tetracycles derivatives, novel compounds obtained and their application in therapy
03/29/2000EP0972184A4 Luminescent transition metal-ligand complex and sensor, probe, system and method based thereon for detecting polar solvents
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor
03/29/2000CN1248580A Process for preparing monacid salt of tonorfloxacin
03/28/2000US6043369 [1,3,4] Triazolo [1,5-A] pyridines
03/28/2000US6043366 Useful in treating disorders involving the orphanin fq(a seventeen amino acid long peptide) receptor.
03/28/2000US6043257 Amidinoindoles, amidinoazoles, and analogs thereof
03/28/2000US6043252 Carboline derivatives
03/28/2000US6043248 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
03/28/2000US6043240 Useful as antipsychotic and analgesic agents
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015631A1 Naphthopyrans annelated in c6-c7, their preparation and compositions and (co)polymer matrices containing them
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015222A1 FUSED PYRIDINE INHIBITORS OF cGMP PHOSPHODIESTERASE
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1999052892A3 Novel herbicides
03/23/2000CA2351548A1 Naphthopyrans annelated in c6-c7, their preparation and compositions and (co)polymer matrices containing them
03/23/2000CA2342583A1 Fused pyridine inhibitors of cgmp phosphodiesterase
03/22/2000EP0987264A1 4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them
03/22/2000EP0987262A1 Quinoline derivatives
03/22/2000EP0987254A1 Novel cyclic diamine compounds and medicine containing the same
03/22/2000EP0986560A1 Pyrrolo 2,1,5-cd]indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
03/22/2000EP0986559A1 1,6-naphthyridine anti-convulsants
03/22/2000EP0986386A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/22/2000EP0986382A1 Raf kinase inhibitors
03/22/2000EP0790997B1 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
03/22/2000EP0775114B1 Process for making antimicrobial compounds
03/22/2000CN1248257A Compound for inhibition of gastric acid secretion
03/22/2000CN1248253A Tricyclic compounds useful for inhibition of farnesyl protein transferase
03/22/2000CN1248251A Disubstituted bicyclic heterocycles, their production and use as medicaments
03/22/2000CN1247865A Prepn. of quinolone and 1,8-diaza-naphthalenone carboxylic acid
03/22/2000CN1050605C Cycloalkano-indole and -azaindole derivatives, its prepn. and medical composition containing them
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040327 Benzimidazole, benzoxazole and benzothiazole compounds
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal
03/21/2000US6040309 Benzothiophene derivatives useful in therapy
03/21/2000US6039969 Immune response modifier compounds for treatment of TH2 mediated and related diseases
03/17/2000CA2282112A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
03/16/2000WO2000014089A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000013508A1 Fused-benzene derivatives useful as herbicides
03/16/2000WO2000008014A8 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect
03/16/2000WO1999065910A9 Fused azepinone cyclin dependent kinase inhibitors
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/16/2000WO1999055706A9 Imidazo pyridine derivatives which inhibit gastric acid secretion
03/16/2000CA2343536A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000CA2342882A1 Chemokine receptor antagonists and methods of use therefor
03/15/2000EP0985671A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT
03/15/2000EP0984967A1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus
03/15/2000EP0984947A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
03/15/2000EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity
03/14/2000US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis
03/14/2000US6037349 Imidazopyridines
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/09/2000WO2000012510A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
03/09/2000WO2000012503A1 Naphthyridine derivatives and process for the preparation thereof
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012501A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012089A1 Novel angiogenesis inhibitors
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012047A2 Enhancement of return to independent living status with a growth hormone secretagogue
03/09/2000WO2000005230A8 Pyrazole derivatives and salts thereof
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342245A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341649A1 Enhancement of return to independent living status with a growth hormone secretagogue
03/09/2000CA2341409A1 Novel angiogenesis inhibitors
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0984008A2 Nitrosation process
03/08/2000EP0983270A1 PROCESS FOR PREPARING 6-$i(O)-MONOESTERS OF CASTANOSPERMINE
03/08/2000EP0983269A1 Process for preparing heterocyclic compounds
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983244A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
03/08/2000EP0800527B1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
03/08/2000EP0784623B1 Naphthyridine derivatives
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 646